Spray drying

Abstract Nowadays, most of the newly developed active pharmaceutical ingredients (APIs) consist of cohesive particles with a mean particle size...

Abstract Background: Dry powders offer the potential to increase stability and reduce cold-chain requirements associated with the distribution of vaccines and...

Abstract Kollidon® SR is one of the recent versatile coprocessed excipients in the formulation of modified release dosage forms. It...

Abstract Proteins have recently caught attention as potential excipients for amorphous solid dispersions (ASDs) to improve oral bioavailability of poorly...

Abstract As it adds so many advantages to the finished formulations, excipient utilised in pharmaceutical dosage forms is a special...

Abstract Background: Spray drying, whilst a popularly employed technique for powder formulations, has limited applications for large-scale proliposome manufacture. Objectives:...

Abstract This study investigates the improvements in direct compaction powder properties achieved through particle design using laboratory and pilot-scale spray...

Abstract Background: Active pharmaceutical ingredient (API) content is a critical quality attribute (CQA) of amorphous solid dispersions (ASDs) prepared by spraying...

Abstract Previously, a nasal powder formulation of the influenza vaccine was proposed to ensure its stability over fifteen months at...

Abstract Amorphous solid dispersions (ASDs) have been extensively utilized to improve the bioavailability of drugs that have low aqueous solubility....